JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study | 146 |
Total Visits Per Month
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study | 1 | 1 | 1 | 8 | 7 | 14 | 3 |
Top country views
| Views |
|---|
Top cities views
| Views |
|---|
